Jimenez-Aleman, G. H., et al. · 2021 · Pharmaceuticals research
doi:10.3390/ph14101048 PMID:34681272 PMC8538351
| Gene ID | Name | Evidence / Role | Function (this paper) |
|---|---|---|---|
| Mp3g02320 | MpC1HDZ | experimental subject | The Mpc1hdz mutant, impaired in oil body formation and thus defective in secondary metabolite accumulation, was tested in antiviral assays. Extracts still showed clear protective activity below cytotoxic doses, indicating the antiviral metabolite is independent of oil-body secondary metabolism. |
| Mp2g26590 | MpCOI1 | experimental subject | The Mpcoi1-2 mutant, impaired in dn-OPDA (jasmonate) perception and thus in defense metabolite induction, was tested in viral assays. Extracts retained antiviral activity, supporting that the active compound (pheophorbide A) derives from primary rather than jasmonate-dependent secondary metabolism. |